According to Renovaro Biosciences's latest financial reports the company's current EPS (TTM) is -1,91ย โฌ. In 2022 the company made an earnings per share (EPS) of -1,95ย โฌ a decrease over its 2021 EPS that were of -0,75ย โฌ.